NOEL PREVOST: Open Payments
NPI 1003942061 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 51 payments from 11 companies in 2025. Trend: 2023 $571 · 2024 $1,222 · 2025 $2,073
Food & beverage: $2,073
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $671 |
| Janssen Biotech, Inc. | 8 | $332 |
| Regeneron Healthcare Solutions, Inc. | 3 | $266 |
| UCB, Inc. | 4 | $232 |
| ABBVIE INC. | 11 | $186 |
| Arcutis Biotherapeutics, Inc. | 4 | $150 |
| Janssen Scientific Affairs, LLC | 1 | $101 |
| Lilly USA, LLC | 3 | $62 |
| LEO Pharma Inc. | 1 | $38 |
| Organon LLC | 1 | $22 |
Products named: TREMFYA, Rhapsido, COSENTYX, Zoryve, RINVOQ, SKYRIZI, EBGLYSS, ANZUPGO.
Industry payments across PA — which companies pay providers there.
